Genomics Market Size, Trends, and Insights By Application (Functional genomics, Pathway analysis, Biomarker discovery, Epigenetics, Others), By Deliverables (Products, Services), By End User (Pharmaceutical and biotechnology companies, Clinics and hospitals, Government institutes, and academic institutes, Clinical research, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Thermo Fisher Scientific Inc.
- Agilent Technologies
- Pacific Biosciences of California Inc.
- Others
Reports Description
According to Custom Market Insights (CMI), The Global Genomics Market Size was valued at USD 24.2 billion in 2021 and is expected to reach USD 29.4 billion in 2022 and is estimated to reach USD 73.4 billion by the end of 2030 at a CAGR of approximately 16.4% during the forecast period 2022-2030.
There has been a buoyant demand for the genomics market in recent years, primarily due to the impact of the outbreak of the COVID-19 pandemic. It showed staggering and unprecedented growth in recent years due to the outbreak of the COVID-19 pandemic. As a result, there was a sudden growth in the market due to increased demand. In addition, genomics has proved all its scientific abilities for treating, preventing, and managing various diseases.
In recent years and the years to come, the market shall see a gradual shift towards precision medicines as compared to the conventional methods used for treatment, and this type of change is expected to play a significant part in the market’s growth in the coming years.
Genome sequencing has become a vital tool for detecting various types of critical diseases like cancer. It is predicted that cancer cases are expected to increase during the forecast period, and it is about to grow to 29.5 million by the year 2040. And the death toll is expected to grow to about 16.4 million yearly. Therefore, the demand for DNA information analysis, sequencing, and storage will be highly beneficial in the coming years.
It will provide better products and software that will help meet the growing demand for genomics in the coming years. All these factors will help the market’s growth during the forecast period.
Many new entrants in the market are expected to provide good opportunities for market growth in the coming years. Furthermore, as many service providers offer sequencing services, the market is expected to grow well in the coming years. In addition, there has been an increase in investments made in the research and development activities associated with bioinformatics. As a result, there will be positive growth in the market during the forecast period.
Growth Factors
The healthcare sector has seen a drastic change due to the outbreak of the pandemic in the past. Many nations worldwide were affected so that the market will grow well in the coming years. The Pharmaceutical industry and biotechnological organizations have engaged in research activities and invested a considerable amount in developing better vaccinations and safer and easier treatments for the COVID-19 pandemic. By monitoring and understanding the genome sequence, the spread of the virus, which affects humans, was studied, and its effect on the genome of humans was understood. This information is being used to develop enhanced treatments.
A few nations launched a set of laboratories in 2020 by collaborating with CDC Africa. Many countries like China, Nepal, Vietnam, and the United States studied gene structure. The virus’s origin was traced, and the drugs were developed in the past. Significant market growth opportunities are expected to be provided due to the increase in the number of research activities conducted by the various institutes of various nations. Many startups are also engaged in the bio-informatics sector, which will provide significant opportunities for market growth in the coming years. Government funding for various nations has also increased the research and development activities are expected to grow.
The demand for different types of sequencing products is expected to grow in the coming years as research in the field has increased to a great extent. As the demand for personalized medicine has risen in recent years, it shall provide significant opportunities for the growth of the genomics market during the forecast period. Different pharmaceutical companies have increased the number of investments in the research activities associated with personalized medicines. These research activities will help the practitioners in the personalized medicine sector to detect the specific requirement of every patient, and the prescription of the drugs will be made for those cases. The treatments will also be decided based on the research made by the medical practitioners.
The outcomes of such practice provide guaranteed results. There has also been a large number of advancements in the gene therapy field, and it has a high potential to replace the currently used drugs and the performance of various surgeries for treating patients. Cost-saving therapy is one of the significant factors that will help in the growth of the market in the coming years. Patient compliance is another factor that will increase the demand for gene therapy in the coming years. It provides drug safety and early detection, which could be life-saving for the patient, and all of these factors will help in the market’s growth in the coming years.
The therapies used for various patients could be personalized or optimized based on the need for the cure or the treatment. Microarray technologies have also proved to be a revolutionary advancement in personalized medicine, which will help grow the market in the coming years. In addition, for clinical testing, new drugs are developed by research organizations and pharmaceutical organizations on a larger scale.
Genomics market segment based on Application
Based on Application, the functional genomics segment is expected to have a larger market share in the coming years. The feature had a good amount of claims in terms of revenue which was about 32% in the past, and it will continue to grow well in the coming years. Maximum revenue was generated through the RTPCR tests conducted in the past.
The fastest compound annual growth rate will be registered through the pathway analysis segment in the coming years. It is a significant part of the research associated with life sciences and the development of drugs. People engaged in the research field use pathway analysis extensively to ensure an enhanced understanding of molecular and cellular biology.
Genomics market segment based on the Deliverables
Based on deliverables, the product segment will have a larger market share. It had a share of about 69% in the past and will continue to grow well in the coming years. Maximum revenue will be generated by launching the nucleic acid extraction reagents. Most of the market players in the genomics market are engaged in acquiring smaller companies to improve their market share.
Genomics market segment based on the End User
The pharmaceutical and biotechnology segment is expected to grow well in the coming years. Their market share is expected to be higher than the other end-user industries. It held a share of about 60% in the past and will continue to grow well in the coming years.
The demand for genomics technologies in the biotechnology and pharmaceutical industry has increased as the number of research activities conducted in this field has also increased. Many companies are offering genomics tests that are directly provided to consumers, and this is increased in recent years, due to which there has been a change in the business models. Pharmaceutical companies receive genomics data from companies that deal with personal genomics, and as data acquisition has become cheap, many new market players have entered the market as there has been a good demand in recent years.
Report Scope
| Feature of the Report | Details |
| Market Size in 2021 | USD 24.2 billion |
| Projected Market Size in 2030 | USD 73.4 billion |
| CAGR Growth Rate | 16.4% CAGR (2022-2030) |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Prominent Players | Thermo Fisher Scientific Inc., Agilent Technologies, Pacific Biosciences of California Inc., QIAGEN N.V., Quest diagnostics, Myriad Genetics Inc., Eppendorf AG, Beijing Genomics Institute (BGI), Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., G.E. Healthcare, Illumina Inc., Oxford Nanopore Technologies, Eurofins Scientific, Color, 23andMe Inc., and Others |
| Key Segment | By Application, Deliverables, End User, and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfill your requirements for research. |
Regional Insights
Based on geography, the North American region will have a larger market share in the coming years. This region has had a good share in the past, estimated at 36% in revenue, and will continue to grow. Strategic partnerships have also played an essential role in the market’s growth in the North American region.
Funds provided by public and private organizations in the North American part will help increase such activities. In addition, many major companies in this field are in the North American region and will help grow the market in the coming years. As that has also been an increase in the approvals from the regulatory authorities of the North American region, the market will continue to grow in the coming years.
The availability of favorable reimbursement policies and change in the regulations that support the market is expected to provide significant opportunities for market growth in the coming years.
Imagenetics received support from organizations like Northshore University’s health system and Color genomics to improve decision-making. The Asia Pacific region is also expected to grow well in the coming years.
The genomics market is expected to grow as research organizations take several initiatives. Research programs undertaken by the organizations in the make sure Pacific region will help in the growth of the market in the coming years. To enable genetic discoveries in Asia, a project was started which was named GenomeAsia 100K. About four various countries throughout Asia were studied under this project.
The regulatory bodies support the market’s growth, which will be a significant factor that will help the market’s growth as the number of approvals in this field has also increased in recent years. In the European region, the demand for genomics is expected to grow, and the growing population in this region will provide excellent opportunities for the market.
To ensure food safety and nutritional security, the market will continue to grow in the coming years. The regulatory framework in the European region has been modified to improve the research work in this area. As a result, the revenue generated by the market in the European region will grow in the coming years.
Key Players
- Thermo Fisher Scientific Inc.
- Agilent Technologies
- Pacific Biosciences of California Inc.
- QIAGEN N.V.
- Quest diagnostics
- Myriad Genetics, Inc.
- Eppendorf AG
- Beijing Genomics Institute (BGI)
- Bio-Rad Laboratories
- Danaher Corporation
- Hoffmann-La Roche Ltd.
- GE Healthcare
- Illumina Inc.
- Oxford Nanopore Technologies
- Eurofins Scientific
- Color
- 23andMe Inc.
Recent Development
- GRAIL was acquired by Illumina in the year 2021 with the aim of making available the DNA sequencing test to a large base of consumers.
- A new product was launched in the year 2020 by Nebula Genomics which would offer the entire genome sequencing to customers at a price of U.S. dollars 299.
Segments covered in the report
By Application
- Functional genomics
- Pathway analysis
- Biomarker discovery
- Epigenetics
- Others
By Deliverables
- Products
- Services
By End User
- Pharmaceutical and biotechnology companies
- Clinics and hospitals
- Government institutes and academic institutes
- Clinical research
- Others
On the basis of Geography
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Genomics Market, (2022 – 2030) (USD Billion)
- 2.2 Global Genomics Market: snapshot
- Chapter 3. Global Genomics Market – Industry Analysis
- 3.1 Genomics Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increase In The Number Of Research Activities
- 3.2.2 The Bio-Informatics Sector
- 3.2.3 The Demand For Personalized Medicine
- 3.2.4 Increase In The Number Of Research Activities
- 3.2.5 The Bio-Informatics Sector
- 3.2.6 and The Demand For Personalized Medicine
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Application
- 3.7.2 Market attractiveness analysis By Deliverables
- 3.7.3 Market attractiveness analysis By End User
- Chapter 4. Global Genomics Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Genomics Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Genomics Market – Application Analysis
- 5.1 Global Genomics Market overview: By Application
- 5.1.1 Global Genomics Market share, By Application, 2021 and 2030
- 5.2 Functional genomics
- 5.2.1 Global Genomics Market by Functional genomics, 2022 – 2030 (USD Billion)
- 5.3 Pathway analysis
- 5.3.1 Global Genomics Market by Pathway analysis, 2022 – 2030 (USD Billion)
- 5.4 Biomarker discovery
- 5.4.1 Global Genomics Market by Biomarker discovery, 2022 – 2030 (USD Billion)
- 5.5 Epigenetics
- 5.5.1 Global Genomics Market by Epigenetics, 2022 – 2030 (USD Billion)
- 5.1 Global Genomics Market overview: By Application
- Chapter 6. Global Genomics Market – Deliverables Analysis
- 6.1 Global Genomics Market overview: By Deliverables
- 6.1.1 Global Genomics Market share, By Deliverables, 2021 and 2030
- 6.2 Products
- 6.2.1 Global Genomics Market by Products, 2022 – 2030 (USD Billion)
- 6.3 Services
- 6.3.1 Global Genomics Market by Services, 2022 – 2030 (USD Billion)
- 6.1 Global Genomics Market overview: By Deliverables
- Chapter 7. Global Genomics Market – End User Analysis
- 7.1 Global Genomics Market overview: By End User
- 7.1.1 Global Genomics Market share, By End User, 2021 and 2030
- 7.2 Pharmaceutical and biotechnology companies
- 7.2.1 Global Genomics Market by Pharmaceutical and biotechnology companies, 2022 – 2030 (USD Billion)
- 7.3 Clinics and hospitals
- 7.3.1 Global Genomics Market by Clinics and hospitals, 2022 – 2030 (USD Billion)
- 7.4 Government institutes
- 7.4.1 Global Genomics Market by Government institutes, 2022 – 2030 (USD Billion)
- 7.5 academic institutes
- 7.5.1 Global Genomics Market by academic institutes, 2022 – 2030 (USD Billion)
- 7.6 Clinical research
- 7.6.1 Global Genomics Market by Clinical research, 2022 – 2030 (USD Billion)
- 7.1 Global Genomics Market overview: By End User
- Chapter 8. Genomics Market – Regional Analysis
- 8.1 Global Genomics Market Regional Overview
- 8.2 Global Genomics Market Share, by Region, 2021 & 2030 (USD Billion)
- 8.3. North America
- 8.3.1 North America Genomics Market, 2022 – 2030 (USD Billion)
- 8.3.1.1 North America Genomics Market, by Country, 2022 – 2030 (USD Billion)
- 8.3.1 North America Genomics Market, 2022 – 2030 (USD Billion)
- 8.4 North America Genomics Market, by Application, 2022 – 2030
- 8.4.1 North America Genomics Market, by Application, 2022 – 2030 (USD Billion)
- 8.5 North America Genomics Market, by Deliverables, 2022 – 2030
- 8.5.1 North America Genomics Market, by Deliverables, 2022 – 2030 (USD Billion)
- 8.6 North America Genomics Market, by End User, 2022 – 2030
- 8.6.1 North America Genomics Market, by End User, 2022 – 2030 (USD Billion)
- 8.7. Europe
- 8.7.1 Europe Genomics Market, 2022 – 2030 (USD Billion)
- 8.7.1.1 Europe Genomics Market, by Country, 2022 – 2030 (USD Billion)
- 8.7.1 Europe Genomics Market, 2022 – 2030 (USD Billion)
- 8.8 Europe Genomics Market, by Application, 2022 – 2030
- 8.8.1 Europe Genomics Market, by Application, 2022 – 2030 (USD Billion)
- 8.9 Europe Genomics Market, by Deliverables, 2022 – 2030
- 8.9.1 Europe Genomics Market, by Deliverables, 2022 – 2030 (USD Billion)
- 8.10 Europe Genomics Market, by End User, 2022 – 2030
- 8.10.1 Europe Genomics Market, by End User, 2022 – 2030 (USD Billion)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Genomics Market, 2022 – 2030 (USD Billion)
- 8.11.1.1 Asia Pacific Genomics Market, by Country, 2022 – 2030 (USD Billion)
- 8.11.1 Asia Pacific Genomics Market, 2022 – 2030 (USD Billion)
- 8.12 Asia Pacific Genomics Market, by Application, 2022 – 2030
- 8.12.1 Asia Pacific Genomics Market, by Application, 2022 – 2030 (USD Billion)
- 8.13 Asia Pacific Genomics Market, by Deliverables, 2022 – 2030
- 8.13.1 Asia Pacific Genomics Market, by Deliverables, 2022 – 2030 (USD Billion)
- 8.14 Asia Pacific Genomics Market, by End User, 2022 – 2030
- 8.14.1 Asia Pacific Genomics Market, by End User, 2022 – 2030 (USD Billion)
- 8.15. Latin America
- 8.15.1 Latin America Genomics Market, 2022 – 2030 (USD Billion)
- 8.15.1.1 Latin America Genomics Market, by Country, 2022 – 2030 (USD Billion)
- 8.15.1 Latin America Genomics Market, 2022 – 2030 (USD Billion)
- 8.16 Latin America Genomics Market, by Application, 2022 – 2030
- 8.16.1 Latin America Genomics Market, by Application, 2022 – 2030 (USD Billion)
- 8.17 Latin America Genomics Market, by Deliverables, 2022 – 2030
- 8.17.1 Latin America Genomics Market, by Deliverables, 2022 – 2030 (USD Billion)
- 8.18 Latin America Genomics Market, by End User, 2022 – 2030
- 8.18.1 Latin America Genomics Market, by End User, 2022 – 2030 (USD Billion)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Genomics Market, 2022 – 2030 (USD Billion)
- 8.19.1.1 The Middle-East and Africa Genomics Market, by Country, 2022 – 2030 (USD Billion)
- 8.19.1 The Middle-East and Africa Genomics Market, 2022 – 2030 (USD Billion)
- 8.20 The Middle-East and Africa Genomics Market, by Application, 2022 – 2030
- 8.20.1 The Middle-East and Africa Genomics Market, by Application, 2022 – 2030 (USD Billion)
- 8.21 The Middle-East and Africa Genomics Market, by Deliverables, 2022 – 2030
- 8.21.1 The Middle-East and Africa Genomics Market, by Deliverables, 2022 – 2030 (USD Billion)
- 8.22 The Middle-East and Africa Genomics Market, by End User, 2022 – 2030
- 8.22.1 The Middle-East and Africa Genomics Market, by End User, 2022 – 2030 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Thermo Fisher Scientific Inc.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Agilent Technologies
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Pacific Biosciences Of California Inc.
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 QIAGEN N.V.
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Quest Diagnostics
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Myriad Genetics Inc.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Eppendorf AG
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Beijing Genomics Institute (BGI)
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Bio-Rad Laboratories
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Danaher Corporation
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 F. Hoffmann-La Roche Ltd.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 G.E. Healthcare
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Illumina Inc.
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Oxford Nanopore Technologies
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Eurofins Scientific
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Color
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 23andme Inc.
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.1 Thermo Fisher Scientific Inc.
List Of Figures
Figures No 1 to 27
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2030
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Key Players
- Thermo Fisher Scientific Inc.
- Agilent Technologies
- Pacific Biosciences of California Inc.
- QIAGEN N.V.
- Quest diagnostics
- Myriad Genetics, Inc.
- Eppendorf AG
- Beijing Genomics Institute (BGI)
- Bio-Rad Laboratories
- Danaher Corporation
- Hoffmann-La Roche Ltd.
- GE Healthcare
- Illumina Inc.
- Oxford Nanopore Technologies
- Eurofins Scientific
- Color
- 23andMe Inc.
- Others
FAQs
“North American” region will lead the global Genomics market during the forecast period 2022 to 2030.
The key factors driving the market are personalized medicine and Cost saving therapy.
The key players operating in the Genomics market are Thermo Fisher Scientific Inc., Agilent Technologies, Pacific Biosciences of California Inc., QIAGEN N.V., Quest diagnostics, Myriad Genetics Inc., Eppendorf AG , Beijing Genomics Institute (BGI), Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina Inc., Oxford Nanopore Technologies, Eurofins Scientific, Color, 23andMe Inc..
The global Genomics market is expanding growth with a CAGR of approximately 19.4% during the forecast period (2022 to 2030).
The global Genomics market size was valued at USD 24.2 billion in 2021 and it is projected to reach around USD 73.4 billion by 2030.